Home > News > Monday's Health Winners & Losers
July 2nd, 2007
Monday's Health Winners & Losers
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
Nanometrics Announces Upcoming Investor Events November 19th, 2014
Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014
Arrowhead to Present at Upcoming Conferences November 15th, 2014
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
NMTI announces breakthrough solutions for HAMR nanoantenna for next-generation ultra-high density magnetic storage November 21st, 2014
Quantum mechanical calculations reveal the hidden states of enzyme active sites November 20th, 2014
UO-industry collaboration points to improved nanomaterials: University of Oregon microscope puts spotlight on the surface structure of quantum dots for designing new solar devices November 20th, 2014
Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014